Full Protocol Guide

BPC 157 5mg + TB500 5mg

A research-use combined recovery peptide entry for product verification and clinician-guided safety review.

BPC 157 5mg + TB500 5mg product vial
BPC 157 5mg + TB500 5mg vial Performance, Recovery & Muscle
ProductBPC 157 5mg + TB500 5mg
CategoryPerformance, Recovery & Muscle
FormatBPC 157 5mg + TB500 5mg vial
ReviewSource-linked guide

Contents

Use this guide as a structured review page. The same headings appear for every protocol so clients and the care team can scan the page consistently.

Quickstart Highlights

TB-500 & BPC-157 dosage protocol combines two research peptides often used together for synergistic tissue repair and recovery.

  • TB-500 (5 mg/week standard) injected once or twice weekly
  • BPC-157 ~500 mcg/day (can be split into 1–2 daily doses)
  • Recommended 4–6 week cycle or longer, based on research needs
  • Reconstitute each vial with bacteriostatic water up to 3 mL
  • Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

BPC-157 (5 mg Vial): Advanced / Aggressive Approach
Week Daily Total (mcg) Per Injection Units (mL) Frequency
Weeks 1–2 750 mcg/day ~375 mcg ~7.5 units (0.075 mL) 2× per day
Weeks 3–4 500 mcg/day 500 mcg ~10 units (0.1 mL) 1× per day
  • Reconstitute with 2 mL of bacteriostatic water to achieve a concentration of 2.5 mg/mL. Each full vial = 5 mg total.
  • This approach splits the 5 mg weekly dose into two subcutaneous injections. At 2.5 mg per injection, you’ll draw about 1 mL (100 units) if reconstituted to 2 mL total.
  • Draw 2.0 mL of bacteriostatic water into a sterile syringe.
  • Inject slowly along the vial wall to minimize foam.
  • Gently swirl the vial—avoid vigorous shaking.
  • Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.
  • Gradually taper from 2 smaller doses to a single daily dose if desired. With 2 mL total volume, 1 mg is ~0.4 mL (40 units). Typical ~500 mcg/day usage remains easy to measure above 10 units.
  • Reconstitute with 1 mL of bacteriostatic water for a 5 mg/mL solution.
  • An advanced protocol may push to 10 mg weekly by administering 5 mg twice per week. Mixing with just 1 mL of water yields ~5 mg per 1 mL (100 units). If 5 mg in a single injection feels too high, split it into smaller doses.
  • Draw 1.0 mL of bacteriostatic water into a sterile syringe.
  • Inject slowly along the vial wall.
  • Gently swirl—avoid vigorous shaking.
  • Reconstitute with 2 mL of bacteriostatic water, resulting in 2.5 mg/mL. Ideal for daily or split-daily injections.
  • Inject along the vial wall slowly to reduce foaming.
  • Gently swirl—avoid shaking vigorously.
  • Reconstitute with 1 mL of bacteriostatic water for a 5 mg/mL concentration.
  • Smaller injection volumes can be harder to measure. If going below ~10 units, consider using a 50-unit or 30-unit syringe for better accuracy.
  • Inject slowly; gently swirl until dissolved.
  • You can run both peptides simultaneously:
  • TB-500: 5–10 mg weekly (1–2 injections each week)
  • BPC-157: ~500 mcg/day, or an advanced protocol up to ~750 mcg/day
  • Each peptide reconstituted in its own vial; do not mix in the same syringe
  • Users often report synergistic recovery effects with both peptides. Administering them on the same day is fine; just use separate syringes and injection sites if desired.

Supplies Needed

Basic materials for a 4–6 week cycle.

  • Peptide Vials:• TB-500 (5 mg Vial)• BPC-157 (5 mg Vial)(Adjust based on total duration)
  • Insulin Syringes: 1 per injection (30–100 unit size)
  • Bacteriostatic Water: 1× 30 ml or as needed
  • Alcohol Swabs: 1 box

Protocol Overview

A concise weekly (TB-500) and daily (BPC-157) injection strategy.

Dosing Protocol

Recommended approach for combining both peptides effectively.

  • Injection Method: Subcutaneous, rotating sites
  • TB-500 Schedule: Typically 2 injections per week (e.g., Monday & Thursday)
  • BPC-157 Schedule: Daily or split daily for Weeks 1–4, optional taper afterward
  • Timing: Separate syringes; no need for precise timing alignment
  • Duration: 4+ weeks, re-assess based on progress

Storage Instructions

Proper handling preserves peptide quality.

  • Lyophilized: Keep frozen until ready to mix
  • Reconstituted: Store at 2–8°C; use within 30 days
  • Protect from light; keep vials upright if possible
  • Avoid repeated freeze-thaw cycles

Important Notes

Tips for safe, consistent usage.

  • Use new, sterile insulin syringes every time; rotate injection sites.
  • Maintain consistent protocol; peptides often show best results with regular use.
  • Monitor for adverse reactions; consult a professional if needed.
  • Do not mix TB-500 and BPC-157 in the same syringe.

How This Works

Both peptides are known for supporting tissue repair in various research settings.

Potential Benefits & Side Effects

Research suggests various therapeutic benefits, with some caution advised.

Injection Technique

Simple guidelines for safe daily injections.

  • Clean vial rubber stopper & injection site with alcohol swabs
  • Insert needle at a 45–90° angle into subcutaneous tissue
  • Inject slowly & rotate sites (abdomen, thigh, etc.)

Lifestyle Factors

Simple habits can complement peptide usage.

  • Adopt a balanced, protein-rich diet
  • Engage in regular exercise; allow sufficient recovery
  • Focus on stress management and adequate sleep

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

  • Do not start, stop, combine, or change a protocol based only on website content.
  • Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References

– PatientPop PDF (Obesity / AOD-9604 Study)

  • TB-500 (5mg Vial) & BPC-157 (5mg Vial) Open source
  • Frontiers in Endocrinology (2021) — Progress on the Function and Application of Thymosin β4 View Source Open source
  • Annals of the New York Academy of Sciences — Thymosin β4: roles in development, repair, and engineering of the cardiovascular system View Source Open source
  • Frontiers in Pharmacology (2022) — Pharmacokinetics, distribution, metabolism, and excretion of BPC-157 View Source Open source
  • HSS Journal (2025) — Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review View Source Open source
  • Current Pharmaceutical Design (2018) — Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract View Source Open source
  • Journal of Orthopaedic Surgery and Research (2019) — BPC 157 and its effects on tendon healing View Source Open source
  • CDC (2024) — Vaccine Administration: Subcutaneous (SUBCUT) Injection View Source Open source
  • NCBI Bookshelf (2023) — Administration of Parenteral Medications – Nursing Skills View Source Open source
  • CDC (NCHS) — Laboratory Procedure Manual: C-Peptide in Serum (storage guidelines) View Source Open source
  • CDC (2023) — General Best Practice Guidelines for Immunization: Vaccine Administration View Source Open source
  • Pure Lab Peptides — TB-500 (5 mg) product page View Source Open source
  • Pure Lab Peptides — BPC-157 (5 mg) product page View Source Open source